This seminar series will be discussing issues of generalizability, transportability, and representation in Alzheimer’s disease (AD) diagnosis and clinical trials. We will be considering the role of AD biomarkers and other eligibility criteria in determining who enters the clinical trials and cohort studies on which we base our conclusions and clinical recommendations.
eBRAIN Goes to Bologna
PNA Faculty Dr. Caterina Rosano recently visited the University of Bologna in Italy as a Visiting Fellow of the university’s Institute of Advanced Studies (ISA). During her stay, she worked alongside faculty and doctoral students in Movement Science, exchanging ideas...








